Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
Amylyx Pharmaceuticals (Nasdaq: AMLX) has announced its participation in two major investor conferences in March 2025. The company will deliver a corporate presentation and Q&A session at the TD Cowen 45th Annual Health Care Conference on March 4 at 10:30 a.m. ET in Boston. Additionally, Amylyx will participate in a fireside chat at the Leerink Global Healthcare Conference on March 10 at 2:20 p.m. ET in Miami.
Both presentations will be accessible via live webcast through the company's investor relations website under the 'Events and Presentations' section. The webcasts will remain available for replay for 90 days after the events.
Amylyx Pharmaceuticals (Nasdaq: AMLX) ha annunciato la sua partecipazione a due importanti conferenze per investitori a marzo 2025. L'azienda presenterà una relazione aziendale e una sessione di domande e risposte alla 45ª Conferenza Annuale sulla Salute di TD Cowen il 4 marzo alle 10:30 ET a Boston. Inoltre, Amylyx parteciperà a una chiacchierata informale alla Conferenza Globale sulla Salute di Leerink il 10 marzo alle 14:20 ET a Miami.
Entrambe le presentazioni saranno accessibili tramite webcast dal vivo attraverso il sito web delle relazioni con gli investitori dell'azienda nella sezione 'Eventi e Presentazioni'. I webcast rimarranno disponibili per il replay per 90 giorni dopo gli eventi.
Amylyx Pharmaceuticals (Nasdaq: AMLX) ha anunciado su participación en dos importantes conferencias para inversores en marzo de 2025. La compañía ofrecerá una presentación corporativa y una sesión de preguntas y respuestas en la 45ª Conferencia Anual de Salud de TD Cowen el 4 de marzo a las 10:30 a.m. ET en Boston. Además, Amylyx participará en una charla informal en la Conferencia Global de Salud de Leerink el 10 de marzo a las 2:20 p.m. ET en Miami.
Ambas presentaciones serán accesibles a través de un webcast en vivo a través del sitio web de relaciones con inversores de la compañía en la sección 'Eventos y Presentaciones'. Los webcasts estarán disponibles para su reproducción durante 90 días después de los eventos.
아밀릭스 제약 (Nasdaq: AMLX)은 2025년 3월에 있을 두 개의 주요 투자자 회의에 참여한다고 발표했습니다. 이 회사는 3월 4일 오전 10시 30분 ET에 보스턴에서 열리는 TD Cowen 제45회 연례 건강 관리 회의에서 기업 발표와 Q&A 세션을 진행할 것입니다. 또한 아밀릭스는 3월 10일 오후 2시 20분 ET에 마이애미에서 열리는 리어링크 글로벌 건강 관리 회의에서 파이어사이드 채팅에 참여할 예정입니다.
두 발표 모두 회사의 투자자 관계 웹사이트의 '이벤트 및 발표' 섹션을 통해 라이브 웹캐스트로 접근할 수 있습니다. 웹캐스트는 이벤트 후 90일 동안 재생할 수 있도록 제공됩니다.
Amylyx Pharmaceuticals (Nasdaq: AMLX) a annoncé sa participation à deux grandes conférences pour investisseurs en mars 2025. L'entreprise présentera une présentation corporative et une session de questions-réponses lors de la 45e Conférence Annuelle de Santé de TD Cowen le 4 mars à 10h30 ET à Boston. De plus, Amylyx participera à une discussion informelle lors de la Conférence Mondiale de Santé de Leerink le 10 mars à 14h20 ET à Miami.
Les deux présentations seront accessibles via un webinaire en direct sur le site web des relations avec les investisseurs de l'entreprise dans la section 'Événements et Présentations'. Les webinaires resteront disponibles en replay pendant 90 jours après les événements.
Amylyx Pharmaceuticals (Nasdaq: AMLX) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im März 2025 angekündigt. Das Unternehmen wird am 4. März um 10:30 Uhr ET in Boston eine Unternehmenspräsentation und eine Q&A-Session auf der 45. jährlichen Gesundheitskonferenz von TD Cowen halten. Darüber hinaus wird Amylyx am 10. März um 14:20 Uhr ET an einem Fireside-Chat auf der Leerink Global Healthcare Conference in Miami teilnehmen.
Beide Präsentationen werden über einen Live-Webcast über die Website der Investor Relations des Unternehmens im Abschnitt 'Veranstaltungen und Präsentationen' zugänglich sein. Die Webcasts bleiben 90 Tage nach den Veranstaltungen für die Wiederholung verfügbar.
- None.
- None.
-
TD Cowen 45th Annual Health Care Conference: Corporate Presentation and Q&A on Tuesday, March 4, 2025, at 10:30 a.m. ET in
Boston, Massachusetts -
Leerink Global Healthcare Conference: Fireside chat on Monday, March 10, 2025, at 2:20 p.m. ET in
Miami, Florida
A live webcast of both presentations can be accessed under “Events and Presentations” in the Investor section of the Company’s website, https://investors.amylyx.com/events-presentations, and will be available for replay for 90 days following the events.
About Amylyx Pharmaceuticals
At Amylyx, our mission is to usher in a new era of treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are currently focused on three investigational therapies across several neurodegenerative, neuroendocrine, and endocrine diseases in which we believe they can make the greatest impact. For more information, visit amylyx.com and follow us on LinkedIn and X. For investors, please visit investors.amylyx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250225475658/en/
Media
Amylyx Media Team
+1 (857) 799-7274
amylyxmediateam@amylyx.com
Investors
Lindsey Allen
Amylyx Pharmaceuticals, Inc.
+1 (857) 320-6244
Investors@amylyx.com
Source: Amylyx Pharmaceuticals, Inc.
FAQ
When is Amylyx Pharmaceuticals (AMLX) presenting at the TD Cowen Healthcare Conference in 2025?
What time is AMLX's fireside chat at the Leerink Global Healthcare Conference?
How long will the webcasts of AMLX's March 2025 investor presentations be available?
Where can investors access the live webcasts of AMLX's March 2025 conference presentations?
